Online
|
|
CIPLA Offers H1N1 Drug to US
Posted by :
wild bullI think this news didn`t help the stock move up... can any one tell why this stock is going down?...
CIPLA Offers H1N1 Drug to US
Posted by : TradeQ
Cipla unveils drug to combat H1N1 virus
Mumbai-based Cipla has launched Oseltamivir, a generic version of Roche s Tamiflu, used in the treatment of the H1N1 virus, under the brand name, Antiflu, in India. Cipla s Oseltamivir brand will cost Rs 475 for 10 capsules, and its 75 ml syrup will be similarly priced. Cipla s drug is also pre-qualified by the World Health Organisation (WHO). The H1N1 virus outbreak from the early part of the year was declared a pandemic in June and continues to spread globally. On Monday, the health ministry said more than 500 people have died from the flu in India since the first fatality was reported in August, with Maharashtra seeing the largest toll of 207 deaths. More than 14,000 people have tested positive for the flu across India during the period. More than 5,700 people have died worldwide since the virus was first discovered in April. Influenza, a perceivably benign condition, kills about 2.5 to 5 lakh people every year worldwide, according to the WHO. These are generally the elderly or those with chronic conditions of the lung, heart or kidney. The fatality pattern this year with the 2009 H1N1 virus has been unusual, with the virus attacking healthy adults and children and pregnant women, said JA Gogtay, medical director, Cipla. The company s shares closed at Rs 304.75 on the BSE (^BSESN : 16849.6 0) on Wednesday, up 1.43%. According to YK Hamied, chairman, Cipla, the company has offered to supply Antiflu to the United States. There is a shortage in the US. We have made an offer. It s up to them, he said. Cipla can produce two million doses of Oseltamivir a month if needed, he added....
Huge Break Out is eminent
Posted by : abhishek.anandI totally second that.. ...
Huge Break Out is eminent
Posted by :
grkothariLarge accumulation today @306. Expect a huge break out this week if the market remains in green....
Good Working ...
CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS
Posted by :
ar_akmHi scorpio76, Best work done. Updation is needed to stay in the market. Thanks!...
CIPLA-NEXT TARGET
Posted by : tara23wait for good buying times to come...november may be a golden month to acquire...
CIPLA-NEXT TARGET
Posted by : scorpio76
DEAR TARA JI,
HI
CAN WE SEE 305-307 LEVELS ON CIPLA TODAY OR IN COMING WEEK, IF NIFTY STARTS CLIMBING AGAIN.
RGDS...
CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS
Posted by : peddasaiThough you are right as far as Hajj stats are concerned and its consequences, i advise the traders not to enter at the moment, as the govt stock piled many other drugs which are equally efficient and effective in fighting virus. Further 82 per cent raise is only holding price, otherwise, in the current correction, the price would have been 140 level. watch out for melt to-day...
CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS
Posted by : tara23a good result from once upon a time best company...
CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS
Posted by : scorpio76
Cipla to launch ayurveda and homeo products in India
BS Reporter / Mumbai/ Ahmedabad October 30, 2009, 0:09 IST
Pharmaceutical major Cipla India Ltd., under the brand name of its associate, L`amar Natural Products Pvt Ltd, will launch ayurvedic, homeopathic and cosmetic products in India in the coming months. The company, which launched its baby products recently, is in the process of research and development on its ayurvedic product, which includes diabetic capsules and the richest antioxidant, according to Ashok Naik, national sales manager — OTC division Cipla India Ltd.
After exporting various products all these years Cipla, under the brand name of its sister concern, L`amar, is planning to introduce natural products, homeopathic products, cosmetics and perfumes in the Indian market soon. While 20 products will be launched under cosmetics segment by January, 40 and 25 products will be launched under ayurvedic and homeopathic segments, respectively. The company is conducting an R&D on ayurveda diabetes capsules and the richest antioxidant on earth, made out of vegiberries found in China, parts of Tibet, Mongolia and the Himalayas. We are the pioneers of preparing antioxidants out of the vegiberry dryfruit and will launch the products in the next three to four months," Naik said, at a press meet in Ahmedabad to launch the company`s baby care products in Gujarat.
The five baby care products, which include baby oil, powder, soap, lotion and gripe water, will be marketed under platinum marketing, all India business partner for OTC product of Cipla India. The company also plans to launch a cough syrup, pain relief balm, anti-lice lotion and two baby food products in a month.
"The company expects a market share of Rs 40 crore from the over Rs 2,000 crore baby care products market in India and Rs 15 lakh per month from Gujarat. In order to retain its image as a pharma company, Cipla has decided to launch the products under the Rs 1500 crore Paris-headquartered L`amar", Naik added. Currently L`amar exports products to various markets in the Middle East, south East Asia, Africa, Latin America, Australia and Europe.
Cipla recorded an 82 per cent rise in its net profit for the July-September quarter this fiscal.
...
Cipla to launch ayurveda and homeo products in India -Business Standard
Posted by : scorpio76
Pharmaceutical major Cipla India Ltd., under the brand name of its associate, L`amar Natural Products Pvt Ltd, will launch ayurvedic, homeopathic and cosmetic products in India in the coming months. The company, which launched its baby products recently, is in the process of research and development on its ayurvedic product, which includes diabetic capsules and the richest antioxidant, according to Ashok Naik, national sales manager — OTC division Cipla India Ltd.
"After exporting various products all these years Cipla, under the brand name of its sister concern, L`amar, is planning to introduce natural products, homeopathic products, cosmetics and perfumes in the Indian market soon. While 20 products will be launched under cosmetics segment by January, 40 and 25 products will be launched under ayurvedic and homeopathic segments, respectively. The company is conducting an R&D on ayurveda diabetes capsules and the richest antioxidant on earth, made out of vegiberries found in China, parts of Tibet, Mongolia and the Himalayas. We are the pioneers of preparing antioxidants out of the vegiberry dryfruit and will launch the products in the next three to four months," Naik said, at a press meet in Ahmedabad to launch the company`s baby care products in Gujarat.
The five baby care products, which include baby oil, powder, soap, lotion and gripe water, will be marketed under platinum marketing, all India business partner for OTC product of Cipla India. The company also plans to launch a cough syrup, pain relief balm, anti-lice lotion and two baby food products in a month.
"The company expects a market share of Rs 40 crore from the over Rs 2,000 crore baby care products market in India and Rs 15 lakh per month from Gujarat. In order to retain its image as a pharma company, Cipla has decided to launch the products under the Rs 1500 crore Paris-headquartered L`amar", Naik added. Currently L`amar exports products to various markets in the Middle East, south East Asia, Africa, Latin America, Australia and Europe.
Cipla recorded an 82 per cent rise in its net profit for the July-September quarter this fiscal.
...
CIPLA TO GAIN DURING HAJJ
Posted by : scorpio76
Saudis Try to Head Off Swine Flu Fears Before Hajj-Cipla to Gain
By DONALD G. McNEIL Jr.
Published: October 29, 2009
Every year, the single largest gathering on the planet is the annual pilgrimage to Mecca: 2.5 million people from 160 countries packed into a small city in Saudi Arabia for five days.
This year, some will be bringing swine flu.
The Saudi authorities, fearing that the hajj could turn their holy city into a petri dish for viral mutations and a hub for spreading a new pandemic wave around the world, are working hard to head that off. They have asked some worshipers, including pregnant women and the elderly, not to make the trip, which is scheduled for the last week of November.
“The hajj is a central ritual of Islam, and our country tries to make it easy for everyone to come,” said Dr. Ziad A. Memish, the country’s assistant deputy minister for preventive medicine. “We’ve said we won’t turn away anyone who arrives at our borders. But we are recommending to other countries whom they should let come.”
Although the Saudis have turned to the World Health Organization and other health agencies for help in previous public health threats to the hajj, this year the Centers for Disease Control and Prevention, the American government’s lead disease-fighting agency, is more deeply involved because it has so much experience with this new flu strain. Consultants for the centers have gone back and forth to Riyadh, flu experts at American medical schools have been called in and the United States Navy’s medical laboratory in Cairo is preparing to help with any complex flu testing that is beyond what Saudi laboratories can do.
While religious pilgrimages feed the souls of those who attend, they often endanger the bodies. There have been several outbreaks of meningitis in Mecca since 1987, and in 2004, Muslim pilgrims spread polio from northern Nigeria across Africa to Saudi Arabia and from there outward to Yemen and Indonesia.
In July 2008, about 200,000 Catholics from all over the world converged on Sydney, Australia, for World Youth Day, attended by the new pope, Benedict XVI, during the Southern Hemisphere’s winter. There was a major flu outbreak, and a Tamiflu-resistant strain of seasonal flu established itself and then spread to the Northern Hemisphere, including to the United States, last winter.
The Saudis reacted because this new strain is the first pandemic flu since 1968. Any new flu carries the risk of gene-swapping that can form mutant viruses, and this one has some swine and avian genes that, before this April, had never been seen in humans. Both the new strain and seasonal flus will be circulating in the world, increasing the risk of flus mixing in Mecca. Also, although the flu infects younger people, the ones most likely to need hospitalization or die if they do get infected are the very young, pregnant women, the sick and the aged.
The hajj offers many opportunities to a virus that spreads through the air and lingers on surfaces: Pilgrims crowded into planes, boats, buses and tent cities; the endless ranks of the faithful praying shoulder to shoulder and touching their hands to the floors around the Kaaba, to handrails as they run between the hills Safa and Marwah, or to cups of water from the Zamzam Well.
A paper published online on Thursday in the journal Science describes many of the obstacles to fighting transmission there. Dr. Memish, the Saudi official, is a co-author with several Centers for Disease Control experts.
The Saudi government has made many preparations, like buying stockpiles of generic Tamiflu from Cipla, an Indian company. The country has 76 health facilities staffed for the hajj, and intensive-care units have been expanded. For pilgrims, all medical care for problems they develop during their visit is free.
...
